Seven Eight Capital’s Fresenius Medical Care FMS Stock Holding History

Seven Eight Capital’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-24,190	Closed	-$514K	–	557
2023 Q1	$514K	Buy	+24,190	New	+$463K	0.11%	238

Other funds holding FMS

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Seven Eight Capital's FMS Position: Q2 2023 in Review

Seven Eight Capital sold out of Fresenius Medical Care (FMS) in Q2 2023, closing a stake of 24,190 shares — an estimated $514K sold.

Seven Eight Capital first reported a position in FMS in Q1 2023 and held it in 1 quarter. The position peaked at $514K in Q1 2023. 146 funds tracked by Wall St. Rank hold FMS as of Q2 2023.

Seven Eight Capital reported no remaining Fresenius Medical Care position as of Q2 2023 after selling out during the quarter.
Seven Eight Capital sold 24,190 Fresenius Medical Care shares in Q2 2023, an estimated $514K.
Seven Eight Capital first reported a position in Fresenius Medical Care in Q1 2023 and held it in 1 quarter.
Seven Eight Capital's Fresenius Medical Care position peaked at $514K in Q1 2023.
146 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2023.

Based on Seven Eight Capital's 13F filing for Q2 2023, filed 14 Aug 2023.